Clinical Trial Update: Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients [Phase 1]

View source ↗

Summary

This entry notes a Phase 1 clinical trial evaluating a cancer immunotherapeutic PCI strategy in patients with triple-negative breast cancer; the study is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Triple Negative Breast Cancer | Phase 1 | Status: NOT_YET_RECRUITING